BECN1 and breast cancer: In contrast, the overexpression of Beclin1 in highly resistant BT-549 and MDA-MB-231 breast cancer cells activated autophagy and inhibited cell proliferation during normal culture conditions and, paradoxically, increased cell survival under starvation, hypoxia, or doxorubicin stimulation [173].